Stefan Oelrich
Stefan Oelrich is the head of Bayer's pharmaceutical division, where he is known for overseeing the development of significant new treatments, including Nubeqa, a drug for prostate cancer that has been described as potentially the largest product the company has ever produced. Under his leadership, Bayer is working on innovative solutions and strategies to enhance efficiency within the company.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 8.00 | 0.17% | +0% | 8,654,622 | 14,376 | $700,000 | 1,163$ |
| Totals | 1 | 8,654,622 | 14,376 | $700,000 | 1,163$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Stefan Oelrich, head of Bayer's pharmaceuticals division, spoke positively about a new drug for prostate cancer.
8